Curesponse vs EdiTy Therapeutics

Curesponse vs EdiTy Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Curesponse is on 55/100 and EdiTy Therapeutics on 19/100.

Curesponse logo
CuresponsePersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
Try Curesponse
EdiTy Therapeutics logo
EdiTy TherapeuticsDeveloping a novel immune cell-based delivery platform for intracellular therapeutic protein transfer.
Try EdiTy Therapeutics

Where each one leads

Curesponse

  • our overall score: 55/100 against 19/100
  • agent readiness: 50/100 against 42/100
  • domain rating: 17/100 against 5/100
  • LinkedIn following: 2,570 against 799

EdiTy Therapeutics

Leads on none of the measures we hold for both companies.

At a glance

MeasureCuresponseEdiTy Therapeutics
What it isPersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.Developing a novel immune cell-based delivery platform for intracellular therapeutic protein transfer.
CategoryLife Sciences, Cancer, Genomics, Genome SequencingLife Sciences, Immunology, Biotech, Genome Editing
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware
Founded20172020
HeadquartersTel Aviv, IsraelNot published
StatusInactiveActive

Size, funding and growth

MeasureCuresponseEdiTy Therapeutics
Employees1416
Headcount growthLast 12 months-4.3%Not published
Total funding$28.0MNot published
Latest roundSeries BSeed
LinkedIn followers2,570799

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCuresponseEdiTy Therapeutics
StartupHub scoreOur 0-100 rating55/10019/100
Traction49/10012/100
Team70/100Not published
Search visibility25/10028/100
Quality58/100Not published
Agent readinessHow well an AI agent can read and act on the siteD (50/100)D (42/100)
Domain ratingLink authority, 0-10017/1005/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCuresponseEdiTy Therapeutics
HostingGoogle CloudGoogle Cloud
CMSNot detectedWordPress

Curesponse vs EdiTy Therapeutics: common questions

Which is better, Curesponse or EdiTy Therapeutics?

On our 0-100 score Curesponse rates higher (55/100 against 19/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.

How do Curesponse and EdiTy Therapeutics compare on the numbers?

Curesponse leads on our overall score (55/100 against 19/100), agent readiness (50/100 against 42/100), domain rating (17/100 against 5/100), LinkedIn following (2,570 against 799).

Read the full Curesponse review and pricing or the EdiTy Therapeutics review and pricing. You can also browse other Curesponse alternatives we track.